Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Physiological Pharmacokinetic Models: Assumption with Protein Binding01:13

Physiological Pharmacokinetic Models: Assumption with Protein Binding

23
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
23
Drug Distribution: Plasma Protein Binding01:29

Drug Distribution: Plasma Protein Binding

4.4K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
4.4K
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

17
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
17
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

21
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
21
Factors Affecting Drug Distribution: Tissue Permeability01:30

Factors Affecting Drug Distribution: Tissue Permeability

101
The drug distribution process within the human body is a complex interplay of various physicochemical properties inherent to the drugs. These properties, including molecular size, ionization degree, partition coefficient, and stereochemical nature, significantly impact how drugs permeate biological membranes to reach their target tissues.
Small molecules with a molecular weight below 500 to 600 Daltons can easily pass through the capillary membrane, gaining access to different tissues. Larger...
101
Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH01:21

Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH

799
Drug absorption within the gastrointestinal (GI) tract is a complex process influenced by several critical factors, including the site pH, the drug's dissociation constant (pKa), and the drug's lipophilicity. The GI tract exhibits a pH gradient, with an acidic environment in the stomach and a more alkaline environment in the small intestine. This pH variation directly affects the ionization state of drugs.
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
799

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Constructing Nano-Trap of CO<sub>2</sub> and C<sub>2</sub>H<sub>6</sub> in an Anion Pillared MOF for Efficient One Step CH<sub>4</sub> Purification.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Identification of a novel major QTL and F-box candidate genes controlling seed dormancy in common wheat.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2026
Same author

SINTER3D: continuous 3D reconstruction of spatial transcriptomics via implicit neural representations.

Genome biology·2026
Same author

spAttClu: a spatial domain clustering model leveraging spatially weighted graph attention and contrastive learning.

Bioinformatics (Oxford, England)·2026
Same author

A Coarse-to-Fine Framework for Oil-Water Interface Measurement in Small-Caliber Transparent Test Tubes.

Sensors (Basel, Switzerland)·2026
Same author

Identification of a Potent and Selective Small-Molecule Inhibitor Targeting the nNOS-PDZ Domain that Exhibits Rapid <i>In Vivo</i> Antidepressant Efficacy.

Journal of medicinal chemistry·2026

Related Experiment Video

Updated: May 12, 2025

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

1.8K

Predicting the Brain-To-Plasma Unbound Partition Coefficient of Compounds via Formula-Guided Network.

Yurong Zou1, Haolun Yuan2, Zhongning Guo1

  • 1State Key Laboratory of Biotherapy and Collaborative Innovation Center of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.

Journal of Chemical Information and Modeling
|May 9, 2025
PubMed
Summary

We developed a deep learning model to predict blood-brain barrier (BBB) permeability, specifically the brain-to-plasma unbound partition coefficient (Kp,uu). This tool aids drug development by improving predictions of how drugs cross the BBB.

More Related Videos

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.9K
Determination of Plasma Membrane Partitioning for Peripherally-associated Proteins
11:11

Determination of Plasma Membrane Partitioning for Peripherally-associated Proteins

Published on: June 15, 2018

8.3K

Related Experiment Videos

Last Updated: May 12, 2025

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

1.8K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.9K
Determination of Plasma Membrane Partitioning for Peripherally-associated Proteins
11:11

Determination of Plasma Membrane Partitioning for Peripherally-associated Proteins

Published on: June 15, 2018

8.3K

Area of Science:

  • Pharmacology
  • Computational Chemistry
  • Neuroscience

Background:

  • Blood-brain barrier (BBB) permeability is critical for brain drug efficacy.
  • The brain-to-plasma unbound partition coefficient (Kp,uu) is a key metric for BBB permeability.
  • Existing Kp,uu data is scarce and empirical prediction models lack broad applicability.

Purpose of the Study:

  • To address the scarcity of Kp,uu data and limitations of existing models.
  • To develop a novel, accurate, and broadly applicable model for predicting Kp,uu.
  • To establish a public dataset for rat Kp,uu values.

Main Methods:

  • Data mining to establish a public rat Kp,uu dataset.
  • Development of a formula-guided deep learning model (CMD-FGKpuu).
  • Validation of the model on multiple benchmark tests.

Main Results:

  • The CMD-FGKpuu model demonstrated strong performance in predicting Kp,uu.
  • The model shows potential for deep learning applications in Kp,uu prediction.
  • The model can be fine-tuned with project-specific data for enhanced utility.

Conclusions:

  • A new deep learning tool (CMD-FGKpuu) effectively predicts BBB permeability (Kp,uu).
  • The study provides a valuable resource for drug development and BBB research.
  • Introduces a novel application of few-shot learning in pharmaceutical research for predicting drug properties.